RALEIGH, N.C. — Nine of the 213 potential coronavirus vaccines in development globally are in Phase III clinical trials, which means they could be a couple of months from approval. But that is only part of the process in moving past the pandemic.
“How fast are we going to be able to make enough vaccine?” asked Pia MacDonald, an epidemiologist with Research Triangle Park-based RTI International. “How are we going to assure accessibility for everyone? What are we going to do about all the people who don’t believe in vaccination?”
North Carolina health officials have been planning since the pandemic began about how to distribute a vaccine. Last week, they submitted a 163-page draft plan to federal officials, outlining who gets the vaccine first, how they’ll get it and how to track their progress.
Continue Reading on WRAL
